Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KVLYZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-B4 monoclonal antibody-DC1 conjugate
|
|||||
| Synonyms |
Anti-B4 monoclonal antibody-DC1 conjugate; AntiB4 DC1; AntiB4-DC1; AntiB4DC1
Click to Show/Hide
|
|||||
| Organization |
ImmunoGen, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Lymphoma [ICD11:2A85-2A90]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-lymphocyte antigen CD19 (CD19)
|
Antigen Info | ||||
| Payload Name |
DC1
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.